Eleven Biotherapeutics Email Format

BiotechnologyMassachusetts, United States11-50 Employees

Eleven Biotherapeutics is a biotechnology company focused on developing fusion protein medicines for cancer. Described as a late-stage enterprise, it aims to advance therapies that could improve outcomes for patients with oncologic diseases. In February 2021, the U.S. Food and Drug Administration accepted for filing the company's biologics license application for Vicineum, a candidate treatment for non-muscle invasive bladder cancer.

Based in Cambridge, Massachusetts, the company operates within the biotechnology research industry and pursues regulatory approval for its fusion protein programs. Its work targets patients with cancer and the clinicians who treat them, with the goal of delivering targeted therapies that address unmet clinical needs. The organization is relatively small, indicating a focused team and potential collaborations within the sector.

Get verified Eleven Biotherapeutics emails free

Company overview Employee directory